CITIC Securities Initiates Coverage on SHOUGANG LANZA with Buy Rating and HK$44 Target Price

Deep News

Aug 23

CITIC Securities has released a research report initiating coverage on SHOUGANG LANZA (02553) with a "Buy" rating and a target price of HK$44, implying a 66.79% upside from the HK$26.38 level at the time of the report's publication. The brokerage projects the company's revenue to reach RMB 657 million, RMB 860 million, and RMB 1.546 billion for the fiscal years 2026, 2027, and 2028 respectively, driven by the gradual commissioning of new projects.

Positioned as a leading specialized and innovative player in AI-powered synthetic biology and CCUS, the company has faced near-term earnings pressure due to fluctuations in gas supply and ethanol prices. However, as product maturity improves and production capacity at its four major bases continues to recover, the company is leveraging its park-based gas supply projects to ease feedstock constraints while expanding through technology licensing models. Combined with the iterative upgrade of its first- and second-generation core technologies and supportive policy tailwinds, the company is advancing multiple new business pipelines, including SAF, green polyethylene, and bioactive peptides, which together underpin substantial long-term growth potential.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1166957911"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1166957911\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1166957911?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-23 12:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1166957911","market":"sg","top_or_hot":-1,"title":"CITIC Securities Initiates Coverage on SHOUGANG LANZA with Buy Rating and HK$44 Target Price","media":"Deep News","content":"<p>CITIC Securities has released a research report initiating coverage on <b>SHOUGANG LANZA</b> (02553) with a \"Buy\" rating and a target price of HK$44, implying a 66.79% upside from the HK$26.38 level at the time of the report's publication. The brokerage projects the company's revenue to reach RMB 657 million, RMB 860 million, and RMB 1.546 billion for the fiscal years 2026, 2027, and 2028 respectively, driven by the gradual commissioning of new projects.<br><br>Positioned as a leading specialized and innovative player in AI-powered synthetic biology and CCUS, the company has faced near-term earnings pressure due to fluctuations in gas supply and ethanol prices. However, as product maturity improves and production capacity at its four major bases continues to recover, the company is leveraging its park-based gas supply projects to ease feedstock constraints while expanding through technology licensing models. Combined with the iterative upgrade of its first- and second-generation core technologies and supportive policy tailwinds, the company is advancing multiple new business pipelines, including SAF, green polyethylene, and bioactive peptides, which together underpin substantial long-term growth potential.<br><br></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CITIC Securities Initiates Coverage on SHOUGANG LANZA with Buy Rating and HK$44 Target Price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCITIC Securities Initiates Coverage on SHOUGANG LANZA with Buy Rating and HK$44 Target Price\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-08-23 12:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CITIC Securities has released a research report initiating coverage on <b>SHOUGANG LANZA</b> (02553) with a \"Buy\" rating and a target price of HK$44, implying a 66.79% upside from the HK$26.38 level at the time of the report's publication. The brokerage projects the company's revenue to reach RMB 657 million, RMB 860 million, and RMB 1.546 billion for the fiscal years 2026, 2027, and 2028 respectively, driven by the gradual commissioning of new projects.<br><br>Positioned as a leading specialized and innovative player in AI-powered synthetic biology and CCUS, the company has faced near-term earnings pressure due to fluctuations in gas supply and ethanol prices. However, as product maturity improves and production capacity at its four major bases continues to recover, the company is leveraging its park-based gas supply projects to ease feedstock constraints while expanding through technology licensing models. Combined with the iterative upgrade of its first- and second-generation core technologies and supportive policy tailwinds, the company is advancing multiple new business pipelines, including SAF, green polyethylene, and bioactive peptides, which together underpin substantial long-term growth potential.<br><br></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02553","symbol_name":"首钢朗泽","start_time":0,"source_url":"","article_id":"1166957911","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1166957911","pubTimestamp":1787460048,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"CITIC Securities has released a research report initiating coverage on SHOUGANG LANZA (02553) with a \"Buy\" rating and a target price of HK$44, implying a 66.79% upside from the HK$26.38 level at the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02553":"首钢朗泽","EWH":"香港ETF-iShares MSCI","BK1159":"石油与天然气的炼制和营销"},"translate_title":"中信证券对首钢蓝沙给予买入评级，目标价44港元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02553":1,"EWH":1},"content_text":"CITIC Securities has released a research report initiating coverage on SHOUGANG LANZA (02553) with a \"Buy\" rating and a target price of HK$44, implying a 66.79% upside from the HK$26.38 level at the time of the report's publication. The brokerage projects the company's revenue to reach RMB 657 million, RMB 860 million, and RMB 1.546 billion for the fiscal years 2026, 2027, and 2028 respectively, driven by the gradual commissioning of new projects.Positioned as a leading specialized and innovative player in AI-powered synthetic biology and CCUS, the company has faced near-term earnings pressure due to fluctuations in gas supply and ethanol prices. However, as product maturity improves and production capacity at its four major bases continues to recover, the company is leveraging its park-based gas supply projects to ease feedstock constraints while expanding through technology licensing models. Combined with the iterative upgrade of its first- and second-generation core technologies and supportive policy tailwinds, the company is advancing multiple new business pipelines, including SAF, green polyethylene, and bioactive peptides, which together underpin substantial long-term growth potential.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}